Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 29, 2008

View Archived Issues

Cerebral ischemia greatly increases protein sumoylation

Cypress acquires Proprius for USD 37.5 million in cash

ProMetic Life Sciences enters license agreement with Kedrion for two hyperimmunes

Soluble CD40 ligand a marker of Alzheimer's disease severity, progression

YM-202074 confers neuroprotection in a stroke model

Alimera enters agreement with Emory to develop new drugs for ophthalmic diseases

Genzyme reported Q4 2007 highlights

AstraZeneca presents update on clinical development of Recentin in NSCLC and colorectal cancer

Recent Pharmacopeia patent reports novel treatment option for autoimmune diseases

Novel agents for treating HCV infection disclosed in recent Genelabs and Gilead patents

New treatments for diabetes and related disorders described in recent patent literature

CNV reduction with picropodophyllin in experimental models

Targeting CCR3 may provide benefit in CNV associated with AMD

ISS recommends that Pharmion stockholders vote for merger agreement with Celgene

Intercell reports results from phase I clinical trial of IC-31 adjuvanted flu vaccine

7TM Pharma reports positive results from two phase I clinical studies of TM-30339 in obesity

MorphoSys and Sigma-Aldrich enter agreement for recombinant research antibodies

GSK and Theravance initiate phase IIb trial of beta-agonist GW-642444 for COPD

FDA accepts and grants priority review to Sirion's NDA for Durezol for ocular inflammation

Positive pharmacokinetic study results of once-daily ondansetron

Anadys initiates phase I ANA-773 trial in cancer patients

Athersys reports results for phase I safety study of novel obesity drug

Evotec commences phase II smoking cessation trial with EVT-302

FDA approves Arcalyst for cryopyrin-associated periodic syndromes (CAPS)

Preliminary results reported from phase III NGX-4010 trial in HIV-DSP

Japan approves Herceptin for early treatment of HER2-positive breast cancer

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...